Colorectal cancer statistics, 2017

Ca-A Cancer Journal for Clinicians - Tập 67 Số 3 - Trang 177-193 - 2017
Rebecca L. Siegel1, Kimberly D. Miller2, Stacey A. Fedewa3, Elizabeth L. Barry4, Reinier Meester5, Afsaneh Barzi6, Ahmedin Jemal7
1Strategic Director, Surveillance Information Services, Surveillance and Health Services Research American Cancer Society Atlanta GA
2Epidemiologist, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA
3Director, Screening and Risk Factor Surveillance, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA
4Professor, Division of Gastroenterology, School of Medicine, University of Colorado, Aurora, CO
5Epidemiologist, Department of Public Health, Erasmus University, Rotterdam, the Netherlands
6Assistant Professor of Clinical Medicine, Department of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
7Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA

Tóm tắt

AbstractColorectal cancer (CRC) is one of the most common malignancies in the United States. Every 3 years, the American Cancer Society provides an update of CRC incidence, survival, and mortality rates and trends. Incidence data through 2013 were provided by the Surveillance, Epidemiology, and End Results program, the National Program of Cancer Registries, and the North American Association of Central Cancer Registries. Mortality data through 2014 were provided by the National Center for Health Statistics. CRC incidence rates are highest in Alaska Natives and blacks and lowest in Asian/Pacific Islanders, and they are 30% to 40% higher in men than in women. Recent temporal patterns are generally similar by race and sex, but differ by age. Between 2000 and 2013, incidence rates in adults aged ≥50 years declined by 32%, with the drop largest for distal tumors in people aged ≥65 years (incidence rate ratio [IRR], 0.50; 95% confidence interval [95% CI], 0.48‐0.52) and smallest for rectal tumors in ages 50 to 64 years (male IRR, 0.91; 95% CI, 0.85‐0.96; female IRR, 1.00; 95% CI, 0.93‐1.08). Overall CRC incidence in individuals ages ≥50 years declined from 2009 to 2013 in every state except Arkansas, with the decrease exceeding 5% annually in 7 states; however, rectal tumor incidence in those ages 50 to 64 years was stable in most states. Among adults aged <50 years, CRC incidence rates increased by 22% from 2000 to 2013, driven solely by tumors in the distal colon (IRR, 1.24; 95% CI, 1.13‐1.35) and rectum (IRR, 1.22; 95% CI, 1.13‐1.31). Similar to incidence patterns, CRC death rates decreased by 34% among individuals aged ≥50 years during 2000 through 2014, but increased by 13% in those aged <50 years. Progress against CRC can be accelerated by increasing initiation of screening at age 50 years (average risk) or earlier (eg, family history of CRC/advanced adenomas) and eliminating disparities in high‐quality treatment. In addition, research is needed to elucidate causes for increasing CRC in young adults. CA Cancer J Clin 2017. © 2017 American Cancer Society. CA Cancer J Clin 2017;67:177–193. © 2017 American Cancer Society.

Từ khóa


Tài liệu tham khảo

10.1002/cncr.24760

10.1002/cncr.22115

Surveillance, Epidemiology, and End Results (SEER) Program, 2016, SEER*Stat Database: Mortality‐All COD, Aggregated With State, Total US (1969‐2014) <Katrina/Rita Population Adjustment>

10.1002/cncr.11380

Surveillance, Epidemiology, and End Results (SEER) Program, 2016, SEER*Stat Database: Incidence‐SEER 9 Regs Research Data (with SEER Delay Factors), Nov. 2015 Sub (1973‐2013) <Katrina/Rita Population Adjustment>‐Linked To County Attributes‐Total US, 1969‐2014 Counties

Surveillance, Epidemiology, and End Results (SEER) Program, 2016, SEER*Stat Database: Incidence‐SEER 18 Regs Research Data with Delay‐Adjustment, Malignant Only, Nov. 2015 Sub (2000‐2013) <Katrina/Rita Population Adjustment>‐Linked To County Attributes‐Total US, 1969‐2014 Counties

Howlader N, 2016, SEER Cancer Statistics Review, 1975‐2013

Surveillance, Epidemiology, and End Results (SEER) Program, 2016, SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence‐Cancer in North America (CiNA) Analytic File, 1995‐2013, for NHIA v2 Origin, Custom File With County, American Cancer Society (ACS) Facts and Figures Projection Project

Centers for Disease Control and Prevention, 2014, Behavioral Risk Factor Surveillance System Survey Data

Centers for Disease Control and Prevention (CDC), 2012, Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates, MMWR Morb Mortal Wkly Rep., 61, 410

National Center for Health Statistics.National Health Interview Survey 2015. Public‐use data file and documentation. Available at:cdc.gov/nchs/nhis/quest_data_related_1997_forward.htm. Accessed July 16 2016.

10.1002/cncr.29659

10.1002/cncr.27404

10.1002/cncr.27405

Fritz A, 2000, International Classification of Diseases for Oncology

10.1093/jnci/djr207

Surveillance Research Program, National Cancer Institute, 2016, SEER*Stat software, version 8.3.2

10.1093/jnci/94.20.1537

Surveillance Research Program, Statistical Methodology and Applications, National Cancer Institute, 2016, DevCan: Probability of Developing or Dying of Cancer, version 6.7.4 [software program]

10.3322/caac.21387

10.1158/1055-9965.EPI-05-0678

10.1002/ijc.25481

10.1093/jnci/djm127

10.1002/cncr.26677

Proctor BD, 2016, Income and Poverty in the United States: 2015. US Census Bureau, Current Population Reports, 60‐256

10.1093/jnci/djs346

10.1158/1055-9965.EPI-12-0023

10.1007/s40615-015-0174-z

10.1093/jnci/djq068

Kelly JJ, 2012, Colorectal cancer in Alaska Native people, 2005‐2009, Gastrointest Cancer Res., 5, 149

10.2105/AJPH.2013.301654

10.1017/S0950268815001181

10.1111/j.1523-5378.2006.00381.x

10.1038/ajg.2012.407

10.1136/gutjnl-2015-310912

10.1158/1055-9965.EPI-15-0082

10.3322/caac.21292

10.1002/ijc.10635

10.1111/j.1440-1746.2007.04923.x

10.1016/j.ejso.2014.11.001

10.1093/jnci/dju427

10.1001/jamaoncol.2016.4227

10.1001/jama.287.16.2106

10.1158/1055-9965.EPI-07-2774

10.3322/canjclin.54.2.78

10.1002/cncr.28509

10.1093/jncimonographs/lgt007

10.1002/cncr.23228

10.1136/jech.2009.096008

10.1093/jnci/djr310

10.1053/j.gastro.2016.01.030

10.3322/CA.2007.0011

10.1158/1055-9965.EPI-07-0329

10.1093/ajcn/82.2.442

10.1002/biof.174

10.1016/j.canlet.2014.02.024

10.1002/ijc.20648

10.1053/j.gastro.2011.04.004

10.1001/jama.297.21.2351

10.1016/S0140-6736(12)62001-7

10.1002/cncr.28789

National Center for Health Statistics, 2016, Health, United States, 2015: With Special Feature on Racial and Ethnic Disparities

Surveillance, Epidemiology, and End Results (SEER) Program, 2016, SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence‐Cancer in North America (CiNA) Analytic File, 1995‐2013, for Expanded Races, Custom File With County, American Cancer Society Facts and Figures Projection Project

10.1002/ijc.24839

10.1111/jgh.12792

10.1016/j.canep.2016.03.009

10.1002/ijc.24343

10.1146/annurev.publhealth.26.021304.144437

10.1001/jama.2016.3829

10.1001/jama.289.4.450

10.1001/jama.2016.20324

10.3322/caac.21349

10.1093/jnci/86.13.997

10.1001/jama.296.23.2815

10.1093/jnci/djv198

Surveillance, Epidemiology, and End Results (SEER) Program, 2016, SEER*Stat Database: Incidence‐SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov. 2015 Sub (1973‐2013 varying)‐Linked To County Attributes‐Total US, 1969‐2014 Counties

10.1056/NEJM198506203122504

10.1200/JCO.2007.14.5631

10.1136/gut.47.4.463

10.1001/jama.1990.03450110090034

10.1200/JCO.1999.17.11.3553

10.1056/NEJMoa032709

Wong RK, 2007, Pre‐operative radiotherapy and curative surgery for the management of localized rectal carcinoma [serial online], Cochrane Database Syst Rev., 2, CD002102

10.1056/NEJMoa040694

10.1016/j.jss.2015.10.021

10.1002/jso.21864

10.1016/j.critrevonc.2016.11.005

10.1200/JCO.2007.14.9930

Knijn N, 2010, Current issues in the targeted therapy of advanced colorectal cancer, Discov Med., 9, 328

10.1002/cncr.21569

10.1007/s10552-014-0344-z

10.1016/j.clcc.2016.03.001

10.1093/annonc/mdu100

10.1016/j.critrevonc.2015.12.015

10.1186/s12916-014-0168-4

10.3945/ajcn.114.094854

10.1001/jamaoncol.2016.0843

10.1002/cncr.29336